Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Kelfred HoldingsHKSE:01134 -7.88%45 EBIT per Share is HK$-0.02 as of Dec. 2025. GuruFocus rates HKSE:01134 with a GF Score™ of 45/100 and a GF Value™ of HK$0.44 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 681 Medical Devices & Instruments companies, Kelfred Holdings ranks worse than 146842.73% on this metric.
Kelfred Holdings's EBIT per Share for the
six
months ended in Dec. 2025 was HK$-0.02.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.02.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Kelfred Holdings's EBIT per Share or its related term are showing as below:
During the past 10 years, the highest 3-Year average EBIT per Share Growth Rate of Kelfred Holdings was -20.60% per year. The lowest was -73.20% per year. And the median was -50.05% per year.
HKSE:01134's 3-Year EBIT Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9.4 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Kelfred Holdings (HKSE:01134) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Kelfred Holdings EBIT per Share Related Terms
Kelfred Holdings EBIT per Share Historical Data
* Premium members only.
The historical data trend for Kelfred Holdings's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$-0.02
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kelfred Holdings (HKSE:01134) has a EBIT per Share of HK$-0.02 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kelfred Holdings and its competitors. According to the industry distribution chart, Kelfred Holdings ranks #999999 out of 681 companies in the Medical Devices & Instruments industry.
Is Kelfred Holdings' EBIT per Share too high?
Kelfred Holdings' current EBIT per Share is HK$-0.02. Based on the distribution chart, Kelfred Holdings ranks #999999 out of 681 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Kelfred Holdings has a GF Score™ of 45/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Kelfred Holdings' EBIT per Share compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Kelfred Holdings ranks #999999 out of 681 companies for EBIT per Share. This places Kelfred Holdings in the lower half of its industry. The industry median EBIT per Share is 9.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.40, based on 681 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Kelfred Holdings and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kelfred Holdings's current EBIT per Share is HK$-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kelfred Holdings stock overvalued right now?
Based on GuruFocus' analysis, Kelfred Holdings (HKSE:01134) is currently considered Significantly Undervalued. The stock's GF Value™ is HK$0.44, compared to a current price of HK$0.22 — trading 49.5% below its estimated fair value. The current EBIT per Share is HK$-0.02. Kelfred Holdings' overall GF Score™ is 45/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Kelfred Holdings (HKSE:01134), the current EBIT per Share is HK$-0.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kelfred Holdings (HKSE:01134) Overvalued in 2026?
Based on GuruFocus' analysis, Kelfred Holdings stock appears to be undervalued.
The current stock price of HK$0.22 is trading 49.5% below its estimated GF Value™ of HK$0.44.
GuruFocus considers Kelfred Holdings to be Significantly Undervalued.
Key valuation signals for HKSE:01134:
EBIT per Share: HK$-0.02
GF Value™: HK$0.44 vs. price of HK$0.22 (49.5% below fair value)
No single metric tells the full story. See the HKSE:01134 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kelfred Holdings Ltd is an investment holding company. The Company and its subsidiaries are principally engaged in the manufacturing and sales of eyewear products. It produces and sells a wide range of spectacle frames and sunglasses mainly through original design manufacturing (ODM) and original equipment manufacturing (OEM) business models. The group offers integrated and customised services, including product design and development, raw materials procurement, production, quality control, packaging, and delivery. The Group also offers (OBM) products under the brand name Miga. It operates in Italy, the United Kingdom, Hong Kong, the U.S., PRC, India, Spain, the Philippines, Japan, Australia, France, and other countries. It generates a majority of its revenue from the United Kingdom.
45GF Score
Get the complete analysis for HKSE:01134
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:01134 has been successfully added to your 
